A fast-spreading horse virus is forcing West Texas owners, arenas and officials to tighten precautions to prevent a ...

(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the positive outcome of its ...

In October, the U.S. Food and Drug Administration (FDA) for the first time ever issued an Emergency Use Authorization (EUA) ...

There are strict rules around reporting a whole range of common health complaints affecting millions of people ...

Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing non-respiratory symptoms, including dermatologic and neurologic manifestations.

The DVLA has confirmed a list of 118 conditions that all motorists must declare to avoid being penalised. This is the ...

The court heard how Wilkins’ dog, Roxy, was left at a veterinary practice in Plymouth on Friday, September 27 last year by an anonymous individual. Upon examination, staff discovered the grey jumper ...

FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The U.S. FDA’s complete response letter (CRL) for Biohaven Ltd.’s lead asset, troriluzole, to treat spinocerebellar ataxia has prompted a wave of downstream changes at the company. There will be a ...

Brief dizzy spells, often dismissed as fatigue, can signal underlying health issues, according to neurologist Dr. Sudhir ...

The New Mexico Livestock Board Office of the State Veterinarian is monitoring an outbreak of equine herpes ...